Acrotech Biopharma Inc.

Acrotech Biopharma is a specialty pharmaceutical company founded in 2018 to develop and commercialize innovative proprietary medications. The company focuses on oncology, hematology, dermatology, neurology, and rare diseases, aiming to address unmet medical needs through a research-based, patient-focused approach. The company operates as a global platform with a strong commercial infrastructure in the United States. It has expanded its portfolio significantly through strategic acquisitions of FDA-approved hematology/oncology assets and continues to pursue internal development and licensing collaborations to advance its pipeline of small molecules and biologics.